This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Reinventing Brainlab
Herzlinger, Regina E.; Dessain, Vincent; Misztal, KarolCase HBS-313069-EStrategyThe management of Germany's Brainlab AG, a leading provider of software-driven oncology and surgery solutions, needs to evaluate strategic options for proceeding without an exclusive hardware partner in its most profitable business segment.Starting at €8.20
-
Angel Investments in Europe and Recent Developments in Crowdfunding
Applegate, Lynda M.; Dessain, Vincent; Billaud, Emilie; Beyersdorfer, DanielaCase HBS-814047-EEntrepreneurshipThis technical note provides information on the evolution and current state of angel investing in Europe. The note first describes the role and types of angel investors, focusing on their investment preferences and practices. It then details the new trends in the market, including the development of policy tools and the proliferation of incubators/accelerators to support angel investors. Finally, the note explores salient issues in angel investin...Starting at €8.20
-
Go Beyond Investing
Applegate, Lynda M.; Dessain, Vincent; Billaud, Emilie; Beyersdorfer, DanielaCase HBS-814046-EEntrepreneurshipIn 2013, Brigitte Baumann, founder of the Pan-European angel investing provider Go Beyond Investing, reflected on the evolution of her venture and the way forward. Her company, which offered deal flow and training to novice and experienced angel investors and ran investor groups in several European countries, had reached a critical size, and Baumann needed to make a strategic decision to ensure its future growth in an industry that was undergoing...Starting at €8.20
-
Sanofi Pasteur: The Dengue Vaccine Dilemma
Rangan, V. Kasturi; Bloom, David E.; Dessain, Vincent; Billaud, EmilieCase HBS-514074-EIn 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a good balanced immune answer, it had a proof of efficacy of only 30%, far below the 70% mark the company had targeted. Guillaume Leroy, vice president of the Dengue Company at Sanofi Pa...Starting at €8.20
-
Economics of Retail Banking Note (Spanish Version)
Frei, Frances X.; Campbell, DennisCase HBS-608S06Service and Operations ManagementEsta nota técnica del estudiante se utiliza en el tercer módulo de un curso sobre Gestión de Servicio de Operaciones, que se ocupa de cómo los administradores de servicios pueden informar a sus decisiones con los datos del cliente (606-097). Explica las operaciones financieras de la banca minorista, que destaca los desafíos que enfrenta la industria de rentabilidad. Para los bancos de Estados Unidos, es bastante común para más de la mitad de la b...Starting at €8.20
-
Bank of Taiwan
Campbell, Dennis; Lau, DawnCase HBS-116058-EAccounting and ControlStarting at €8.20
-
Wawa Inc.
McGarvie, Blythe; Campbell, Dennis; Stack, KristinCase HBS-114086-EAccounting and ControlRetailing requires attention to detail and customer and employee loyalty. Wawa is a 50-year old food retailer with almost a cult-like following. With $9 billion in revenues, Wawa is the 50th largest privately-held company in the US. Learn how they have accomplished consistent 15% annual shareholder returns. The Wawa associates (name for employees) have an ESOP which plays a key role in Wawa's culture of ownership. This case explores the role of i...Starting at €8.20
-
Affinity Plus, Teaching Note
Campbell, DennisTeaching Note HBS-112091-EFinanceTeaching Note for 112091.Starting at €0.00
-
Shangri-La Hotels, Teaching Note
Campbell, DennisTeaching Note HBS-112090-EService and Operations ManagementTeaching Note for 108-006.Starting at €0.00
-
Poles apart on PZU (C)
Gino, Francesca; Dessain, Vincent; Misztal, Karol; Khayyat, MichaelCase HBS-912015-EAfter a decade-long dispute with the Polish State Treasury, in October 2009 the Dutch insurer Eureko agreed to exit PZU in exchange for compensation. Who was the biggest beneficiary of the settlement: Eureko, the Treasury, or PZU itself?Starting at €5.74